New cancer clinical trial: Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer

Published on: March 19, 2018 at 12:00PM
Conditions:   Pancreatic Cancer;   Chemotherapy Effect;   Surgery--Complications
Intervention:   Drug: modified-FOLFIRINOX
Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
Completed
http://ift.tt/2FMhf5v